Catherine Hurd

Visiting Scientist

I am currently a Postdoctoral Researcher within the Crick-GSK Linklabs collaboration, working within Louise Walport's lab at the Crick Institute and the Chemical Biology group at GSK. My project focusses on using the RaPID peptide display technology to generate tools for the study of novel therapeutic targets and to enable the generation of cell-permeable macrocyclic peptides.

I completed my PhD in the Department of Biochemistry at the University of Cambridge in 2020 where I was a member of Jesus College. My PhD work was carried out in the lab of Darerca Owen & Helen Mott and involved the generation of stapled peptides to inhibit GTPase-effector interactions.